retatrutide ly3437943 clinical trial 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in Phase 3 New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide (LY3437943): Mechanism of Action

Single GLP-1 agonists activate only the GLP-1 receptor, producing effects on insulin secretion, appetite regulation, and glucose control

This article provides a side-by-side comparison of the three GHRH analogs

Safety outcomes included tacrolimus levels, creatinine and GFR

The global DNA methylation in the livers of HFD-fed mice was increased, with significant gene-specific hypermethylation of CYP2R1, CYP27A1, CYP27B1, and VDR, and hypomethylation of CYP24A1

My life was slipping away from me. As Megans world got smaller, her depression and body pains grew larger

In a case report by Sani et al., the use of semaglutide 1 mg weekly over 12 months in a male with PWS and diabetes resulted in an HbA1c decrease of 3.9% and weight loss of 5.2 kg (41)